RIPE-KG · Version 1.1.0 · Resource

ripekg:registry-evidence/RIPEA2D330616160C50F0

https://w3id.org/ripe/ripe-kg/registry-evidence/RIPEA2D330616160C50F0
SubjectPredicateObject
ripekg:evaluation/RIPEA2D330616160C50F0 prov:used ripekg:registry-evidence/RIPEA2D330616160C50F0
ripekg:registry-evidence/RIPEA2D330616160C50F0 rdf:type rdfs:Resource
ripekg:registry-evidence/RIPEA2D330616160C50F0 rdf:type owl:Thing
ripekg:registry-evidence/RIPEA2D330616160C50F0 rdf:type ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence
ripekg:registry-evidence/RIPEA2D330616160C50F0 rdf:type ripe:RegistryEvidenceRegistry evidence
ripekg:registry-evidence/RIPEA2D330616160C50F0 rdf:type tido:Evidence
ripekg:registry-evidence/RIPEA2D330616160C50F0 prov:wasAttributedTo ripekg:source/who-ictrpWHO ICTRP
ripekg:registry-evidence/RIPEA2D330616160C50F0 prov:wasAttributedTo ripekg:source/who-ictrpWHO International Clinical Trials Registry Platform
ripekg:registry-evidence/RIPEA2D330616160C50F0 prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEA2D330616160C50F0
ripekg:registry-evidence/RIPEA2D330616160C50F0 prov:wasMemberOf ripekg:research-integrity-assessment/RIPEA2D330616160C50F0
ripekg:registry-evidence/RIPEA2D330616160C50F0 ripe:concerns ripekg:work/10.1111%2F1756-185x.13688Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: A randomized, double‐blind, controlled trial
ripekg:registry-evidence/RIPEA2D330616160C50F0 ripe:registrationAssessmentRationale Registry registration date (study_first_submit_qc_date) is missing or empty.
ripekg:registry-evidence/RIPEA2D330616160C50F0 ripe:registrationId IRCT2017011614925N
ripekg:registry-evidence/RIPEA2D330616160C50F0 ripe:registrationLink https://trialsearch.who.int/Trial2.aspx?TrialID=IRCT2017011614925N
ripekg:registry-evidence/RIPEA2D330616160C50F0 ripe:registryName IRCT
ripekg:registry-evidence/RIPEA2D330616160C50F0 tido:supports ripekg:integrity-assessment-hypothesis/RIPEA2D330616160C50F0-human-2-2
ripekg:registry-evidence/RIPEA2D330616160C50F0 tido:supports ripekg:integrity-assessment-hypothesis/RIPEA2D330616160C50F0-inspectai-2-2